News

FDA warned that Potiga may cause bluish skin predominantly around lips, fingers and toes and pigment changes in the retina, which may lead to loss of vision. GlaxoSmithKline

UMEC is an investigational bronchodilator molecule (formerly known as GSK573719), a long-acting muscarinic antagonist (LAMA), that is administered using the ELLIPTA inhaler. The MAA for UMEC monotherapy has

The affected lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams may show precipitation / crystallization in IV bag or IV line after reconstitution, which results in

Specialised Therapeutics Australia that has license to fidaxomicin in Australia and New Zealand will make the product available in Australia from 14 May 2013. Optimer CEO and board

The US-based study will assess the effectiveness of potent monoclonal Fc optimized anti-CD19 antibody MOR208 in a total of 30 enrolled subjects. Response duration, safety and pharmacokinetics of

Erivedge (vismodegib) is used to treat adults with symptomatic metastatic basal cell carcinoma, or locally advanced basal cell carcinoma not suitable for surgery or radiotherapy. Curis chief executive

Dymista is indicated for the symptomatic treatment of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocortocoid is not considered sufficient.

The approval will allow the company to manufacture and market the generic equivalent of Warner Chilcott Company’s Durice for Oral Suspension 250mg/5mL and 500mg/5mL. Cephalosporin antibiotic is indicated

Phase 3 study was designed to assess the immunogenicity, tolerability and safety of Prevenar 13* in adults between 18 to 49 years of age. When measure one month